index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications avec texte intégral

Open Access

46 %

Mots clés

CTCF Germinal center Myoblasts Conduction disease Anticorps monoclonal Adaptive immunity Acetylcholine receptor Auto-immunité Cellules th17 Maladie auto-immune Neuromuscular junction Gd T cells Glucocorticoids Interferon de type I Interleukine-23 Experimental autoimmune myasthenia gravis CCL21 Interferon Quality of life CXCL13-CXCR5 Interferon-β Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Interferonopathy Genetics FMR1 Thymus Acetylcholine receptors Experimental models Chronic inflammation Cardiomyopathy Endogenous nucleic acids Myasthenia Gravis MG Myasthénie grave CD31 Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Antimir-150 Acetylcholine receptor antibodies Transcriptome Interferon IFN Thymoma Max Autoimmune diseases Interferon type-I MiR-7 Interféron de type I Cytokines Experimental mouse models B cells Immune response MiR-125 Experimental autoimmune myasthenia gravis EAMG Interleukin 23 Human myoblasts Immunology and Microbiology Section Acides nucléiques endogènes Lamin A/C nuclei Early-onset myasthenia gravis Chemokine Complete Freund's adjuvant BAFF Thymic epithelial cells Ectopic germinal centers Chemokines Autoimmune disease MG patients Etiology DICER Clinical cell transplantation Inflammation Long-term follow-up PBMC AChR antibodies Th17 cells Il-23 Autoimmunity Disease susceptibility Inflammatory cytokines Fragile X syndromes Mass cytometry CyTOF Macrophages Chronicity Heart failure COX2 Interferon type I M3243AG Immunity COVID-19 Exercise Centres germinatifs ectopiques Immunotherapy Ferrites LMNA Genetic associations Animal models Myasthenia gravis Innate immunity MYB Germinal centers Immune regulation Gender